Clinical Update
Benfotiamine and ALS

I feel quite fortunate to have introduced benfotiamine to the American medical community some 17 years ago. Since that time, it has been used to improve neurological function in the feet and legs of thousands of people. I have frequently heard of individuals who–while using benfotiamine for their lower extremity neurological symptoms–have experienced improvement in symptoms unrelated to their lower extremity neuropathy.
I've written a paper on the most interesting of these cases, a gentleman with ALS. Cureus, a highly respected peer reviewed journal, just published it. I am very proud of this work and would like to share it with my colleagues.
The paper can be found at: https://www.cureus.com/articles/157487-impaired-thiamine-metabolism-in-amyotrophic-lateral-sclerosis-and-its-potential-treatment-with-benfotiamine-a-case-report-and-a-review-of-the-literature

Article
Richard Mann, DPM, Publishes Case Series on Nutritional Approach to Long COVID Brain Fog
March 10, 2026Dr. Richard H. Mann

Clinical Update
Polyneuropathy, Alzheimer's Disease and Benfotiamine: Neurodegeneration and Vitamin B1 Deficiency
October 3, 2022Dr. Richard H. Mann

Clinical Update
NIH Awards $45 Million to Fund Study on Benfotiamine and Alzheimer's Disease
July 11, 2022Dr. Richard H. Mann
Stay in the loop
New research, plainly explained.
One short email when a study lands that meaningfully changes the picture. No spam, no products.
You can unsubscribe at any time.